In spite of the fact that BATF expression was increased in most tumors, BATF was only associated with clinicopathological stages in BLCA and KIRC, which indicated that BATF is steady during tumor progression into higher grades in other tumors. The gene discussed is BATF; the disease is bladder transitional cell carcinoma.